NEW YORK (GenomeWeb News) – Complete Genomics today said that it and Illumina have settled two patent infringement lawsuits brought by Illumina.

Illumina will dismiss with prejudice both lawsuits as part of the settlement agreement, and Complete Genomics will dismiss with prejudice all its counterclaims.

The two firms have entered into mutual releases. Each will be responsible for its own legal costs, and no payment was made by either party to the other. No licenses are being granted, either.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.